A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Clinical trial NCT02337725 · COMPLETED

Trial details

NCT number: NCT02337725
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2015-02-07
Primary completion: 2016-09-15
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.